End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- AUD | -.--% | -.--% | -.--% |
06-13 | Arovella Therapeutics, Teva Pharmaceuticals End ZolpiMist License Agreement | MT |
06-05 | Arovella Therapeutics Completes Process Development for ALA-101 Manufacturing; Shares Jump 9% | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
53.67B | - | |||||
38.86B | ||||||
38.76B | ||||||
27.27B | ||||||
25.91B |